Literature DB >> 25064202

Sleep apnea prevalence in acute myocardial infarction--the Sleep Apnea in Post-acute Myocardial Infarction Patients (SAPAMI) Study.

Ondrej Ludka1, Radka Stepanova2, Martina Vyskocilova2, Lujza Galkova1, Monika Mikolaskova3, Milos Belehrad2, Jana Kostalova2, Zuzana Mihalova4, Adela Drozdova4, Jiri Hlasensky3, Michal Gacik5, Lucie Pudilova5, Tereza Mikusova6, Blanka Fischerova6, Fatima Sert-Kuniyoshi7, Virend K Somers8, Jindrich Spinar1, Tomas Kara9.   

Abstract

BACKGROUND: While sleep apnea (SA) might be a modifiable cardiovascular risk factor, recent data suggest that SA is severely underdiagnosed in patients after acute myocardial infarction (MI). There is limited evidence about day-night variation of onset of MI on dependence of having SA. We therefore investigated the prevalence of SA and examined the day-night variation of onset of MI in acute MI patients.
METHODS: We prospectively studied 782 consecutive patients admitted to the hospital with the diagnosis of acute MI. All subjects underwent sleep evaluations using a portable device after at least 48 h post-admission. Using the apnea-hypopnea index (AHI), groups were defined as patients without SA (<5 events/h), mild SA (5-15 events/h), moderate SA (15-30 events/h), and severe SA (≥ 30 events/h).
RESULTS: Almost all patients (98%) underwent urgent coronary angiography and 91% of patients underwent primary PCI. Using a threshold of AHI ≥ 5 events/h, SA was present in 65.7% of patients after acute MI. Mild SA was present in 32.6%, moderate in 20.4% and severe in 12.7%. The day-night variation in the onset of MI in all groups of SA patients was similar to that observed in non-SA patients. From 6 AM to 12 PM, the frequency of MI was higher in both SA and non-SA patients, as compared to the interval from 12 AM to 6 AM (all p<0.05).
CONCLUSION: There is a high prevalence of SA in patients presenting with acute MI. Peak time of MI onset in SA patients was between 6 AM and noon, similar to that in the general population. Whether diagnosis and treatment of SA after MI will significantly improve outcomes in these patients remains to be determined.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Day–night variation; Prevalence; Sleep apnea

Mesh:

Year:  2014        PMID: 25064202      PMCID: PMC4249636          DOI: 10.1016/j.ijcard.2014.06.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  30 in total

1.  Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study.

Authors:  V Aboyans; C Cassat; P Lacroix; P Tapie; F Tabaraud; F Pesteil; F Bertin; M Laskar; P Virot
Journal:  Cardiology       Date:  2000       Impact factor: 1.869

Review 2.  Sleep-disordered breathing and cardiovascular disease.

Authors:  Robert Wolk; Tomas Kara; Virend K Somers
Journal:  Circulation       Date:  2003-07-08       Impact factor: 29.690

3.  Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators.

Authors:  Tawfiq Zeidan-Shwiri; Doron Aronson; Khalid Atalla; Miry Blich; Mahmoud Suleiman; Ibrahim Marai; Lior Gepstein; Lena Lavie; Peretz Lavie; Monther Boulos
Journal:  Heart Rhythm       Date:  2010-12-23       Impact factor: 6.343

4.  Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease.

Authors:  H Schäfer; U Koehler; T Ploch; J H Peter
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

5.  Platelet function in patients with obstructive sleep apnoea syndrome.

Authors:  B M Sanner; M Konermann; M Tepel; J Groetz; C Mummenhoff; W Zidek
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

6.  Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease.

Authors:  T Mooe; K A Franklin; U Wiklund; T Rabben; K Holmström
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

7.  Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome.

Authors:  K Dingli; E L Coleman; M Vennelle; S P Finch; P K Wraith; T W Mackay; N J Douglas
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

8.  Circadian variation in the frequency of onset of acute myocardial infarction.

Authors:  J E Muller; P H Stone; Z G Turi; J D Rutherford; C A Czeisler; C Parker; W K Poole; E Passamani; R Roberts; T Robertson
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

9.  Association of sleep apnoea with myocardial infarction in men.

Authors:  J Hung; E G Whitford; R W Parsons; D R Hillman
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  16 in total

1.  Ambulatory screening for obstructive sleep apnea in patients with resistant arterial hypertension.

Authors:  Monika Kamasová; Jan Václavík; Tomáš Václavík; Milada Hobzová; Eva Kociánová; Miloš Táborský
Journal:  Sleep Breath       Date:  2017-10-27       Impact factor: 2.816

Review 2.  Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis.

Authors:  Zhuoshan Huang; Zhengda Zheng; Yanting Luo; Suhua Li; Jieming Zhu; Jinlai Liu
Journal:  Sleep Breath       Date:  2016-08-22       Impact factor: 2.816

3.  Heart rate acceleration runs and deceleration runs in patients with obstructive sleep apnea syndrome.

Authors:  Jie Jiang; Xue Chen; Cheng Zhang; Guangfa Wang; Jing Fang; Jing Ma; Jue Zhang
Journal:  Sleep Breath       Date:  2016-11-23       Impact factor: 2.816

Review 4.  The Link Between Obstructive Sleep Apnea and Cardiovascular Disease.

Authors:  Fré Bauters; Ernst R Rietzschel; Katrien B C Hertegonne; Julio A Chirinos
Journal:  Curr Atheroscler Rep       Date:  2016-01       Impact factor: 5.113

5.  The relationship between apnoea hypopnoea index and Gensini score in patients with acute myocardial infarction undergoing emergency primary percutaneous coronary intervention.

Authors:  Cai-Ping Zhu; Tao-Ping Li; Xiao Wang; Yu-Hua Zhao; Shi-Xi Zhou; Yan Fu; Yi-Wei Jiang; Xue-Ping Xiao
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Acute pulmonary embolism in patients with obstructive sleep apnea: frequency, hospital outcomes, and recurrence.

Authors:  Zeynep Idil Seckin; Haytham Helmi; Timothy J Weister; Augustine Lee; Emir Festic
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

7.  Obstructive Sleep Apnea during REM Sleep and Cardiovascular Disease.

Authors:  R Nisha Aurora; Ciprian Crainiceanu; Daniel J Gottlieb; Ji Soo Kim; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 21.405

8.  Unanticipated Nocturnal Oxygen Requirement during Positive Pressure Therapy for Sleep Apnea and Medical Comorbidities.

Authors:  Safal Shetty; Aaron Fernandes; Sarah Patel; Daniel Combs; Michael A Grandner; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

9.  Perioperative complications in patients with sleep apnea following primary total shoulder arthroplasty: An analysis of 33,366 patients.

Authors:  Christopher A Wang; Joseph R Palmer; Michael O Madden; Wayne Cohen-Levy; Rushabh M Vakharia; Martin W Roche
Journal:  J Orthop       Date:  2019-05-01

10.  Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.

Authors:  Antonia Barcelo; Josep Miquel Bauça; Aina Yañez; Laura Fueyo; Cristina Gomez; Monica de la Peña; Javier Pierola; Alberto Rodriguez; Manuel Sanchez-de-la-Torre; Jorge Abad; Olga Mediano; Jose Amilibia; Maria Jose Masdeu; Joaquin Teran; Josep Maria Montserrat; Mercè Mayos; Alicia Sanchez-de-la-Torre; Ferran Barbé
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.